Ildong Pharmaceutical Co., Ltd. (249420.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.16T
Enterprise Value1.24T
P/E Ratio12.85
PEG Ratio0.01
Price/Sales Ratio0.8
Price/Book Ratio1.65
Enterprise/Revenue0.97
Enterprise/EBITDA12.38

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.16

Income Statement

Revenue566.93B
Revenue/Share20,301.66
Gross Profit214.76B
EBITDA39.9B
Net Income27.66B
Diluted EPS936.77

Balance Sheet

Total Cash59.07B
Total Cash/Share2,093.04
Total Debt133.65B
Total Debt/Equity0.54
Current Ratio0.99
Book Value Per Share8,502.47

Price History

52-Week Change-26.42
52-Week High45,050
52-Week Low14,420
Moving Average 50 Days20,101.2
Moving Average 200 Days28,917.3

Statistics

Average Volume195,018
Shares Outstanding31.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield1.38
Payout Ratio0
Last Split Factor21:20
Last Split DateMarch 05, 2020
AD